xi's moments
Home | Technology

Chinese genomics company BGI reports surging profit in H1

Xinhua | Updated: 2020-08-28 10:19

Scientists check samples awaiting tests in the "Huo-Yan laboratory" of genomics sequencing company BGI in Shenzhen, Guangdong province. [Photo provided to China Daily]

SHENZHEN -- BGI Genomics Co Ltd, China's genomics giant, reported surging profits in the first half (H1) of 2020 due to strong demand for its COVID-19 test kits.

Its net profit edged up 734.2 percent year-on-year to 1.65 billion yuan (about $240 million) in the January-June period, BGI Genomics said in its interim financial report filed with the Shenzhen Stock Exchange.

During the period, the company said it earned revenue of 4.11 billion yuan, a year-on-year increase of 218.1 percent.

In the first six months of 2020, the gene sequencing firm in Shenzhen spent 169.96 million yuan on research and development, up 11.7 percent year-on-year.

Driven by strong business growth, shares of BGI Genomics soared 4.59 percent to close at 145.72 yuan Thursday in Shenzhen.

Global Edition
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349